Trial Profile
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Apr 2013
Price :
$35
*
At a glance
- Drugs Bromfenac (Primary)
- Indications Ocular inflammation; Ocular pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors ISTA Pharmaceuticals
- 09 Apr 2013 US FDA has approved bromfenac according to a Bausch and Lomb media release.
- 17 Aug 2011 New trial record
- 14 Jul 2011 Results of a pooled analysis of two identically-designed studies (204785 and 204793) published in the Current Medical Research and Opinion.